-
Investors Are Watching: Citigroup Inc. (NYSE:C), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Argan (NYSE:AGX), Clifton Bancorp Inc. (NASDAQ:CSBK), Horizon Pharma plc (NASDAQ:HZNP)
On Tuesday shares of Citigroup Inc. (NYSE:C) closed at $53.74. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 25.50%. The Board of Directors of Citigroup Inc. (NYSE:C) declared a quarterly dividend on Citigroup’s common stock of $0.05 per share, payable on May 22, 2015…
-
Stock Runners: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Range Resources Corporation (NYSE:RRC), New York REIT (NYSE:NYRT), Denbury Resources Inc. (NYSE:DNR), Ultragenyx Pharmaceutical (NASDAQ:RARE)
On Friday shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) closed at $6.39. Zacks downgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP) from a hold rating to a sell rating in a report issued on Wednesday. Range Resources Corporation (NYSE:RRC) in last trading activity moved up 5.74% to close at $64.29. Company weekly performance is -0.71% while its quarterly…
-
Trader’s Watch List: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Curis (NASDAQ:CRIS), Avnet (NYSE:AVT), Affiliated Managers Group (NYSE:AMG), First Potomac Realty Trust (NYSE:FPO)
On Wednesday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $64.50. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), announced that it will host a conference call on Monday, May 11, 2015 at 5pm ET to discuss first quarter 2015 financial results and provide a corporate update. Curis, Inc. (NASDAQ:CRIS) in last trading activity decreased -2.60% to close at…
-
Morning Buzz: owo Limited (NASDAQ:WOWO), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Eastman Chemical (NYSE:EMN), Public Storage (NYSE:PSA), Eagle Materials (NYSE:EXP), First Financial Bankshares (NASDAQ:FFIN)
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in last trading activity moved up 6.01% to close at $59.82. Company weekly performance is -14.11% while its quarterly performance stands at 2.96%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is -15.38% away from its 52 week high. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive results from its trial of triheptanoin, for the treatment of…
-
Morning Alert: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Centene Corp. (NYSE:CNC), Owens-Illinois (NYSE:OI), Edison International (NYSE:EIX), Vectren Corporation (NYSE:VVC)
On Tuesday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $59.50. On April 23, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), announced that it has received two orphan drug designations for triheptanoin (UX007). The U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted orphan drug designation for triheptanoin for the treatment of fatty acid…
-
Eye Catching Stocks: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Peregrine Pharmaceuticals (NASDAQ:PPHM), Boston Scientific Corporation (NYSE:BSX), Robert Half International Inc. (NYSE:RHI), Medivation (NASDAQ:MDVN)
On Monday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $63.89. On 23 April, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive data from an investigator-sponsored study on triheptanoin, which is being developed for the treatment of movement disorders associated with glucose transporter type-1 deficiency syndrome (Glut1 DS). Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) in last trading activity moved…
-
Active Watch List: VIVUS Inc. (NASDAQ:VVUS), Cliffs Natural Resources Inc. (NYSE:CLF), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Altera Corp. (NASDAQ:ALTR), Arctic Cat Inc. (NASDAQ:ACAT)
On Thursday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.50. Company’s sales growth for last 5 years was 29.50% and EPS growth for next 5 years is recorded as 6.70%. On April 21, VIVUS, Inc.(NASDAQ: VVUS) , announced that the United States Patent and Trademark Office has issued U.S. Patent Nos. 9,011,905 , covering compositions…
-
Hot Stock List: Fastenal Company (NASDAQ:FAST), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Village Super Market Inc. (NASDAQ:VLGEA), Mad Catz Interactive (NYSEMKT:MCZ), Galena Biopharma (NASDAQ:GALE)
On Tuesday shares of Fastenal Company (NASDAQ:FAST) closed at $41.79. Company’s sales growth for last 5 years was 14.10% and EPS growth for next 5 years is recorded as 14.85%. Fastenal Company (NASDAQ:FAST) reported Tuesday profit for the first quarter that grew 14 percent from last year, reflecting improved operating margins and net sales growth.…
-
Today’s Hot List: Excel Trust (NYSE:EXL), Oasis Petroleum Inc. (NYSE:OAS), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Quantum Corporation (NYSE:QTM), EMC Corporation (NYSE:EMC)
On Friday shares of Excel Trust, Inc. (NYSE:EXL) closed at $15.82. Company’s sales growth for last 5 years was 92.00% and EPS growth for next 5 years is recorded as 5.75%. Excel Trust Inc. (NYSE:EXL) announced Friday morning that it agreed to be acquired by Blackstone Property Partners for $15.85 per share in cash, or…
-
Stock Highlights: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Oxford Immunotec Global PLC (NASDAQ:OXFD), Supertel Hospitality (NASDAQ:SPPR), Epizyme (NASDAQ:EPZM), Gevo (NASDAQ:GEVO)
On Tuesday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $62.09. Wedbush initiated coverage on shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in a research note released on Tuesday morning. The firm issued an outperform rating on the stock. Oxford Immunotec Global PLC (NASDAQ:OXFD) in last trading activity increased 6.10% to close at $14.08. Company weekly…